Regular Strength Acid Reducer

Manufacturer
Family Dollar | Ranbaxy Pharmaceuticals Inc. | Shasun Pharmaceuticals Limited
Effective date
2014-10-14
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:40:44

Label at a glance#

ProductRegular Strength Acid Reducer
Active ingredientRANITIDINE HYDROCHLORIDE
Label structure9 sections

Indications and uses

• relieves heartburn associated with acid indigestion and sour stomach • prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages 

Dosage and administration

• adults and children 12 years and over: • to relieve symptoms, swallow 1 tablet with a glass of water • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn • can be used up to twice daily (do not take more than 2 tablets in 24 hours) • children under 12 years: ask a doctor 

Storage and handling

• TAMPER EVIDENT: DO NOT USE IF THE CARTON OR INDIVIDUAL BLISTER IS OPEN OR TORN • store at 20º - 25ºC (68º - 77ºF) • avoid excessive heat or humidity • this product is sodium and sugar free

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg
(as ranitidine hydrochloride, USP 168 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages 

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or any other acid reducers 

Do not use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor 

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain
  • had heartburn over 3 months. This may be a sign of a more serious condition
  • heartburn with lightheadedness, sweating, or dizziness 
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days 

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. 

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). 

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutesbefore eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
  • children under 12 years: ask a doctor 

Other information

STORAGE AND HANDLING SECTION

  • TAMPER EVIDENT: DO NOT USE IF THE CARTON OR INDIVIDUAL BLISTER IS OPEN OR TORN
  • store at 20º - 25ºC (68º - 77ºF)
  • avoid excessive heat or humidity
  • this product is sodium and sugar free

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, croscarmellose sodium, hyrpomellose, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, talc, titanium dioxide 

Questions

OTC - QUESTIONS SECTION

call 1-800-406-7984

Principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FAMILY
wellness

COMPARE TO THE ACTIVE INGREDIENT OF ZANTAC 150*

Maximum Strength
Acid Reducer
Ranitidine Tablets, USP 150 mg

Prevents & Relieves Heartburn Associated with Acid Indigestion & Sour Stomach

24 TABLETS

DISTRIBUTED BY
FAMILY DOLLAR SERVICES, INC.,
10401 MONROE RD,
MATTHEWS, NC 28105 USA

5110360 0614

MADE IN INDIA

 

Ranitidine_150mg_24's
Ranitidine_150mg_24's

Ranitidine_150mg_24's

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
198191ranitidine 150 MG Oral TabletPSN1
198191ranitidine 150 MG Oral TabletSCD1
198191ranitidine 150 MG (as ranitidine HCl 168 MG) Oral TabletSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
RANITIDINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7f54af34-be54-4c3c-894f-78df6452d747Product name320190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850Product name520190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7bProduct name120180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228Product name120160720

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55319-351-242020-01-31C16284748780-19d75b9d0-65a7-f424-e053-dadaa90a57ceFamily Wellness
55319-351-652020-01-31C16284748780-19d75b9d0-65a7-f424-e053-dadaa90a57ceFamily Wellness

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55319-351-24Regular Strength Acid Reducer3 in 1 CARTONTABLET31
55319-351-24Regular Strength Acid Reducer8 in 1 BLISTER PACKTABLET81
55319-351-65Regular Strength Acid Reducer1 in 1 CARTONTABLET11
55319-351-65Regular Strength Acid Reducer65 in 1 BOTTLETABLET651

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55319-351REGULAR STRENGTH ACID REDUCER (RANITIDINE) TABLET [FAMILY DOLLAR]1Legacy NDC, 4 package rows20141105_bd2b1178-fb3b-4690-b7d0-a2622b91b2cb.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHM1
RANITIDINEACTIVE MOIETY884KT10YB71
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH481
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6751
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU41
TALCINACTIVE INGREDIENT7SEV7J4R1U1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55319-35155319-351-24, 55319-351-65

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 261 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
TALCTALC7SEV7J4R1UCAPSULE, COATED PELLETS / ORAL14 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / RESPIRATORY (INHALATION)0.13 mgExact identifier — unii candidate
39 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TROCHE / ORAL50 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4PELLET / ORAL34 mgExact identifier — unii candidate
49 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOLOTION / TOPICAL0.1 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / RECTAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE / ORAL322 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER, FOR SUSPENSION / ORAL120 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4LOZENGE / ORAL120 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, EXTENDED RELEASE / ORAL117 mgExact identifier — unii candidate
39 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, CHEWABLE / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
TALCTALC7SEV7J4R1UOINTMENT / TOPICAL74.6 %w/wExact identifier — unii candidate
35 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / ORAL72 mgExact identifier — unii candidate
40 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, CHEWABLE / ORAL216 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, EXTENDED RELEASE / TRANSDERMAL49 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPFILM / BUCCAL3 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, SOLUBLE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, EXTENDED RELEASE / ORAL168 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30LOZENGE / TRANSMUCOSAL100 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48GRANULE / ORAL150 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, DELAYED RELEASE / ORAL3.2 mgExact identifier — unii candidate
49 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL0.15 mgExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675SUSPENSION, EXTENDED RELEASE / ORAL2.7 mgExact identifier — unii candidate
21 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, COATED / ORAL49 mgExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1UGUM, CHEWING / BUCCALNAExact identifier — unii candidate
35 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
40 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOCAPSULE, COATED PELLETS / ORAL3.32 mgExact identifier — unii candidate
27 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / ORAL25 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUSPENSION, EXTENDED RELEASE / ORAL70 mgExact identifier — unii candidate
49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, FILM COATED / ORAL992 mgExact identifier — unii candidate
28 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, ORALLY DISINTEGRATING / ORAL41 mgExact identifier — unii candidate
27 equally ranked IID candidates
TALCTALC7SEV7J4R1UPELLET / ORAL69 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / BUCCAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48PELLET / ORAL162 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4INSERT / VAGINAL8 mgExact identifier — unii candidate
49 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, COATED PELLETS / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSHAMPOO, SUSPENSION / TOPICAL3 %w/vExact identifier — unii candidate
40 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET / SUBLINGUAL10 mgExact identifier — unii candidate
22 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, DELAYED RELEASE PARTICLES / ORAL64 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SUSPENSION / ORAL200 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / VAGINAL8 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / NASAL20 mgExact identifier — unii candidate
49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / ORAL6184 mgExact identifier — unii candidate
28 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER / TOPICAL9235 mgExact identifier — unii candidate
35 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, LIQUID FILLED / ORAL106 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, DELAYED RELEASE / ORAL14 mgExact identifier — unii candidate
21 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED, EXTENDED RELEASE / ORAL20 mgExact identifier — unii candidate
35 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
22 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE PELLETS / ORAL24 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, FOR SUSPENSION / ORAL220 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGRANULE, FOR SUSPENSION / ORAL143 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, LIQUID FILLED / ORAL12 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675DROPS / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSYSTEM / TOPICAL420 mgExact identifier — unii candidate
40 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A200536-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2884e616aacf4f…
2026-08-18 06:07:402026-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283f01610625f2…
2019-09-15 20:21 UTC2019-09A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bd2b1178-fb3b-4690-b7d0-a2622b91b2cbbd2b1178-fb3b-4690-b7d0-a2622b91b2cb2014-10-14WarningsExact identifier
spl id: bd2b1178-fb3b-4690-b7d0-a2622b91b2cb
spl set id: bd2b1178-fb3b-4690-b7d0-a2622b91b2cb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.